Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 142
Filtrar
1.
Eur Psychiatry ; 25(6): 361-5, 2010 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-20615670

RESUMEN

OBJECTIVE: In this study, we evaluated brain perfusion in patients with first-episode medicated schizophrenia using the new analytical method, statistical parametric mapping (SPM) applied to single photon emission computed tomography (SPECT). METHOD: We performed SPECT with 99-Tc-ethyl cysteinate dimer (99mTc-ECD) of the brain and magnetic resonance imaging (MRI) in patients with schizophrenia (n=30) and control subjects matched for age and gender (n=37). A voxel-by-voxel group analysis was performed using SPM2 (Z>3.0, P<0.001, uncorrected for multiple comparisons). RESULT: In comparison with control subjects, the volumes of the bilateral frontal areas were found to be decreased on MRI. Blood flow was found to be reduced in the bilateral temporal areas in the patients with schizophrenia on SPECT. CONCLUSION: In this study, patients with first-episode schizophrenia appeared to have significant bilateral temporal hypoperfusion, although temporal volumes were not significantly decreased in comparison with control subjects. Abnormality of temporal lobe blood flow in schizophrenia may show that functional changes occur earlier than structural changes, and may assist in the diagnosis of schizophrenia.


Asunto(s)
Encéfalo/diagnóstico por imagen , Encéfalo/patología , Circulación Cerebrovascular , Cisteína/análogos & derivados , Imagen por Resonancia Magnética , Compuestos de Organotecnecio , Tomografía Computarizada de Emisión de Fotón Único , Adulto , Encéfalo/irrigación sanguínea , Estudios de Casos y Controles , Femenino , Lóbulo Frontal/diagnóstico por imagen , Lóbulo Frontal/patología , Humanos , Masculino , Persona de Mediana Edad , Radiofármacos , Esquizofrenia , Lóbulo Temporal/diagnóstico por imagen , Lóbulo Temporal/patología
2.
Methods Inf Med ; 49(5): 458-61, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20490423

RESUMEN

OBJECTIVES: Sleep stage transitions constitute one of the key components of the dynamical aspect of sleep. However, neural mechanisms of sleep stage transitions have not, to date, been fully elucidated. We investigate the effects of administrating risperidone, a central serotonergic and dopaminergic antagonist, on sleep stage transitions inhumans, and also on ultradian rapid-eye-movement (REM) sleep rhythms. METHODS: Ten healthy young male volunteers (age: 22 ± 3.7 years) participated in this study. The subjects spent three nights in a sleep laboratory. The first was the adaptation night, and the second was the baseline night. On the third night, the subjects received risperidone (1 mg tablet) 30 min before the polysomnography recording. We measured and investigated transition probabilities between waking, REM and non-REM (stages I-IV) sleep stages. RESULTS: We found that the probability of transition from stage II to stage III was significantly greater for the risperidone night than for the baseline night. We also found that risperidone administration prolonged REM-onset intervals, when compared to the baseline night. CONCLUSIONS: We demonstrate that central serotonergic and/or dopaminergic neural transmissions are involved in the regulation of sleep stage transitions from light (stage II) to deep (stage III) sleep, and also in determining ultradian REM sleep rhythms.


Asunto(s)
Antagonistas de Dopamina/farmacología , Risperidona/farmacología , Fases del Sueño/efectos de los fármacos , Administración Oral , Adulto , Humanos , Masculino , Valores de Referencia , Sueño REM/efectos de los fármacos , Adulto Joven
3.
Transplant Proc ; 41(9): 3772-4, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19917385

RESUMEN

AIM: The purpose of the study was to examine changes in splenic volume among recipients during the course of adult-to-adult living donor liver transplantation (LDLT) using multislice computed tomography (CT) scanning with a semiautomatic volumetry software. MATERIALS AND METHODS: Forty-eight patients, including 33 males and a mean overall age of 54 +/- 8 years), underwent liver transplantation for the primary disease of liver cirrhosis with or without hepatocellular carcinoma (n = 31/17, respectively). The mean MELD score was 14 +/- 6. The liver graft mass compared with recipient weight was 74% +/- 28%. Splenic artery embolization was not performed. Dynamic CT scans splenic volume, and platelet counts (10(3)/cm(3)) were obtained pre, < or =50 day and > or =90 days postoperatively. RESULTS: The total time to generate volumetry and image postprocessing per examination was <10 minutes. One-factor analysis of variance (ANOVA) revealed that the average splenic volume tended to be reduced from pre- to post-LDLT, although not significantly: pre-LDLT, 469 +/- 270 mL; < or =day 50, 369 +/- 212 mL; and > or =day 90, 378 +/- 210 mL (P = .066). One-factor ANOVA revealed that the average platelet count was significantly different in the 3 periods: pre-LDLT, 69 +/- 32 x 10(3)/cm(3); < or =day 50, 181 +/- 253 x 10(3)/cm(3); and > or =day 90, 126 +/- 64 x 10(3)/cm(3) (P < .01). The post hoc Scheffé test revealed the statistical significance of the platelet counts between pre-LDLT and < or =day 50 (P < .01). CONCLUSION: Splenic volumetry with multislice CT and semiautomatic software, which is simple and not time consuming, was able to evaluate remission from hypersplenism during the course of LDLT.


Asunto(s)
Cirrosis Hepática/cirugía , Trasplante de Hígado/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Adulto , Carcinoma Hepatocelular/diagnóstico por imagen , Carcinoma Hepatocelular/cirugía , Femenino , Humanos , Hígado/anatomía & histología , Cirrosis Hepática/diagnóstico por imagen , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/cirugía , Donadores Vivos , Masculino , Persona de Mediana Edad , Tamaño de los Órganos , Recuento de Plaquetas , Estudios Retrospectivos , Bazo/anatomía & histología , Bazo/diagnóstico por imagen , Tomógrafos Computarizados por Rayos X
4.
Br J Radiol ; 80(952): e81-4, 2007 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-17551167

RESUMEN

Extracranial vertebral artery aneurysm is uncommon, and the common cause is penetrating trauma. Rupture of extracranial vertebral artery aneurysm into the thoracic cavity is extremely rare and fatal due to haemorrhagic shock by massive haemothorax. We report an intrathoracic rupture of the extracranial vertebral artery aneurysm with neurofibromatosis Type 1, successfully treated by coil and liquid embolisation.


Asunto(s)
Aneurisma Roto/etiología , Embolización Terapéutica/métodos , Hemotórax/etiología , Neurofibromatosis 1/complicaciones , Arteria Vertebral , Adulto , Aneurisma Roto/diagnóstico por imagen , Aneurisma Roto/terapia , Femenino , Hemotórax/terapia , Humanos , Tomografía Computarizada por Rayos X , Arteria Vertebral/diagnóstico por imagen
5.
Acta Radiol ; 47(6): 609-11, 2006 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-16875341

RESUMEN

General paresis (parenchymatous neurosyphilis) is a rare disease, and in recent years the number of papers published on the magnetic resonance imaging findings has been limited. The findings are as follows: cerebral atrophy; mesiotemporal T2 hyperintensity; ventriculomegaly; pathological T2 hypointensity of the globus pallidus, putamen, the head of the caudate nucleus and thalamus. We present a new finding, diffuse cerebral white matter T2 hyperintensity, observed in a patient with general paresis with a 5-year history of progressive dementia.


Asunto(s)
Encefalopatías/diagnóstico , Aumento de la Imagen/métodos , Imagen por Resonancia Magnética/métodos , Neurosífilis/diagnóstico , Adulto , Atrofia , Núcleo Caudado/patología , Ventrículos Cerebrales/patología , Demencia/diagnóstico , Lóbulo Frontal/patología , Globo Pálido/patología , Humanos , Masculino , Lóbulo Parietal/patología , Putamen/patología , Lóbulo Temporal/patología , Tálamo/patología
6.
Acta Radiol ; 46(1): 104-9, 2005 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-15841748

RESUMEN

PURPOSE: To determine whether myotonic dystrophy (MyD) patients have diffusion tensor abnormalities suggestive of microstructural changes in normal-appearing white matter (NAWM). MATERIAL AND METHODS: Conventional and diffusion tensor magnetic resonance images of the brain were obtained in 19 MyD patients and 19 age-matched normal control subjects. Fractional anisotropy (FA) and mean diffusivity (MD) values were calculated in white matter lesions (WMLs) and NAWM in MyD patients and in the white matter of normal control subjects. Differences between WML and NAWM values and between MyD patient and control subject values were analyzed statistically. RESULTS: Significantly lower FA and higher MD values were found in all regions of interest in the NAWM of MyD patients than in the white matter of control subjects (P<0.01), as well as significantly lower FA and higher MD values in WMLs than in NAWM of MyD patients (P < 0.05). There was no significant correlation of mean FA or MD values in NAWM with patient age, age at onset, or duration of illness (P>0.1). CONCLUSION: Diffusion tensor imaging analysis suggests the presence of diffuse microstructural changes in NAWM of MyD patients that may play an important role in the development of disability.


Asunto(s)
Imagen de Difusión por Resonancia Magnética , Distrofia Miotónica/patología , Telencéfalo/patología , Adulto , Anisotropía , Estudios de Casos y Controles , Femenino , Humanos , Procesamiento de Imagen Asistido por Computador , Masculino , Persona de Mediana Edad
7.
Br J Radiol ; 77(921): 728-34, 2004 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-15447957

RESUMEN

Our purpose was to determine whether hepatic portal perfusion assessed by multidetector row CT using compensation for respiratory misregistration can predict the severity of chronic liver disease. We carried out dynamic CT in 43 patients (chronic hepatitis: n=9; cirrhosis: n=24; normal liver: n=10). In this series, 20 patients had liver tumours. The CT protocol was designed to avoid respiratory artefacts and included two interscan breathing periods during the study. To compensate for respiratory misregistration, image sets in the same z-axis position were acquired from four-slice data on each scan, and the portal perfusion calculations were made according to the maximum slope method. Portal perfusion was compared with and without compensation for respiratory misregistration, and the different types of hepatic disease. In the liver tumour patients in particular, portal perfusion was compared with the degree of hepatic fibrosis in the liver sections. Portal perfusion in the patients without compensation for respiratory misregistration (1.10 ml min(-1)ml(-1)) was higher than that of those with compensation (0.99 ml min(-1)ml(-1); p=0.036). Hepatic portal perfusion of patients with chronic hepatitis (0.97 ml min(-1)ml(-1)) and liver cirrhosis (0.88 ml min(-1)ml(-1)) was less than that of patients with normal liver (1.32 ml min(-1)ml(-1); p=0.03, 0.001). Moderate correlation was seen between portal perfusion and the percentage of fibrosis in patients with liver tumours (r=0.55). Hepatic portal perfusion obtained by multidetector row dynamic CT using compensation for respiratory misregistration has the potential to improve non-invasive assessment of the degree of chronic liver disease.


Asunto(s)
Cirrosis Hepática/diagnóstico por imagen , Tomografía Computarizada por Rayos X/métodos , Anciano , Carcinoma Hepatocelular/diagnóstico por imagen , Carcinoma Hepatocelular/patología , Carcinoma Hepatocelular/fisiopatología , Enfermedad Crónica , Femenino , Humanos , Circulación Hepática/fisiología , Cirrosis Hepática/patología , Cirrosis Hepática/fisiopatología , Neoplasias Hepáticas/diagnóstico por imagen , Neoplasias Hepáticas/patología , Neoplasias Hepáticas/fisiopatología , Masculino , Persona de Mediana Edad , Dosis de Radiación
8.
Eur J Neurol ; 10(6): 727-9, 2003 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-14641520

RESUMEN

Jaw-opening dystonia (oromandibular dystonia with jaw-opening; Brueghel's syndrome) is a rare condition, and only a limited number of cases have been reported in the literature. However, many patients may remain undiscovered or misdiagnosed, like a patient described previously. A case (40-year-old man) of jaw-opening dystonia (oromandibular dystonia with jaw-opening; Brueghel's syndrome) is reported. In this case, brain anomalies, cavum septi pellucidi and Verga's ventricle, were observed on magnetic resonance imaging of the brain. This case and a review of the literature indicate the presence of organic factors in the etiology of Brueghel's syndrome. The etiological relationship of brain anomalies in Bruegel's syndrome is discussed.


Asunto(s)
Ventrículos Cerebrales/patología , Síndrome de Meige/patología , Tabique Pelúcido/patología , Adulto , Humanos , Imagen por Resonancia Magnética , Masculino , Pruebas Neuropsicológicas
9.
Acta Radiol ; 44(3): 334-9, 2003 May.
Artículo en Inglés | MEDLINE | ID: mdl-12752008

RESUMEN

PURPOSE: To evaluate the safety of superselective arterial embolization therapy in the lower gastrointestinal tract. The sequelae on normal enteric tissue in lower gastrointestinal arterial embolization were retrospectively reviewed. MATERIAL AND METHODS: To control hemorrhage and tumor blood supply, 14 patients were treated by superselective transcatheter embolization at different levels of the colonic and small intestine vessels via the superior and inferior mesenteric arteries using microcoils and/or gelatin sponge. Normal enteric tissues in the embolized areas were analyzed for the occurrence of ischemic changes by clinical follow-up, colonoscopy, and surgery. RESULTS: Normal bowel function was preserved in 13 patients. In 1 patient treated with numerous gelatin sponge particles delivered from the proximal arcade of the superior mesenteric artery, significant muscular fibrosis occurred. CONCLUSION: Superselective arterial embolization for lower gastrointestinal hemorrhage can be safely performed by minimizing the amount of embolic materials and delivering them as distally as possible.


Asunto(s)
Colon/patología , Embolización Terapéutica , Hemorragia Gastrointestinal/terapia , Intestino Delgado/patología , Colon/irrigación sanguínea , Femenino , Hemorragia Gastrointestinal/patología , Humanos , Intestino Delgado/irrigación sanguínea , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
10.
Pharmacopsychiatry ; 35(4): 155-6, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12163987

RESUMEN

We report a case of Meige syndrome with apraxia of lid opening that lasted for about seven months after discontinuation of sulpiride treatment. To our knowledge, this is the first report demonstrating that Meige syndrome with apraxia of lid opening is induced by sulpiride, and that the condition persists.


Asunto(s)
Antidepresivos de Segunda Generación/efectos adversos , Apraxias/inducido químicamente , Antagonistas de Dopamina/efectos adversos , Enfermedades de los Párpados/inducido químicamente , Síndrome de Meige/inducido químicamente , Sulpirida/efectos adversos , Adulto , Femenino , Humanos
11.
Br J Cancer ; 86(2): 222-5, 2002 Jan 21.
Artículo en Inglés | MEDLINE | ID: mdl-11870510

RESUMEN

We have investigated dihydropyrimidine dehydrogenase expression as a prognostic marker in breast cancer. A total of 119 women with breast cancer undergoing surgery between 1985 and 1996 were included in this study. Eighty-seven patients were treated with postoperative chemotherapy including 5-fluorouracil or 5-fluorouracil derivatives. Fifty-nine (50%) of 119 patients were determined to be immunostaining-positive for dihydropyrimidine dehydrogenase. There was no significant difference between dihydropyrimidine dehydrogenase staining and tumour size, lymph node status, clinical stage, oestrogen receptor status, histologic grade, or 5-fluorouracil administration. When evaluated in patients treated with 5-fluorouracil or 5-fluorouracil derivatives, patients with dihydropyrimidine dehydrogenase-positive tumours had a significantly (P<0.05) poorer disease-free survival compared to those with dihydropyrimidine dehydrogenase-negative tumour. No conclusion can be drawn about the prognostic impact of dihydropyrimidine dehydrogenase status in patients who were not treated with 5-fluorouracil regimes due to the small number of such cases in this series. Lymph node and dihydropyrimidine dehydrogenase status were independent prognostic factors for disease-free survival, and lymph node status for overall survival using multivariate analysis. In conclusion, dihydropyrimidine dehydrogenase is a possible prognostic factor in patients with breast cancer treated with 5-fluorouracil or 5-fluorouracil derivatives.


Asunto(s)
Antineoplásicos/uso terapéutico , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/enzimología , Regulación Neoplásica de la Expresión Génica , Oxidorreductasas/biosíntesis , Adulto , Anciano , Anciano de 80 o más Años , Biomarcadores de Tumor , Neoplasias de la Mama/patología , Quimioterapia Adyuvante , Dihidrouracilo Deshidrogenasa (NADP) , Supervivencia sin Enfermedad , Femenino , Fluorouracilo/administración & dosificación , Humanos , Inmunohistoquímica , Metástasis Linfática , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico
12.
Oncol Rep ; 9(2): 375-8, 2002.
Artículo en Inglés | MEDLINE | ID: mdl-11836611

RESUMEN

It is important to determine which factors are predictive for the prognosis of patients treated with breast conserving surgery (BCS) and radiation therapy (RT) in order to make a decision as to the adjuvant treatment. Although estrogen receptor (ER) is known to be a predictive marker for antiestrogens in breast cancer, the prognostic effect of hormone receptors has not been fully analyzed in Japanese breast cancer patients treated with BCS and RT. A total of 153 breast cancer patients having up to three positive nodes in the axilla as identified histologically and treated with both BCS and RT with or without systemic therapy were enrolled in this study. All tumors were measured for ER and progesterone receptor (PR) using ligand-binding assay (LBA). ER was inversely related to patients' age, however, PR was not related to any clinical features. When ER was classified into negative, weakly positive and strongly positive categories, with cut-off levels of zero and 50 fmol/mg protein, the relapse-free survival (RFS) was significantly better in patients with tumors having strongly positive ER than in patients with tumors having negative ER. Multivariate analysis revealed that ER as well as nodal status, was an independent predictive factor for RFS, however, PR was not. As a result, we believe that ER measured by LBA is valuable for predicting prognosis of early-stage breast cancer patients treated with BCS and RT.


Asunto(s)
Adenocarcinoma Escirroso/terapia , Adenocarcinoma/terapia , Biomarcadores de Tumor/metabolismo , Neoplasias de la Mama/terapia , Receptores de Estrógenos/metabolismo , Adenocarcinoma/metabolismo , Adenocarcinoma/patología , Adenocarcinoma Escirroso/metabolismo , Adenocarcinoma Escirroso/patología , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Neoplasias de la Mama/metabolismo , Neoplasias de la Mama/patología , Quimioterapia Adyuvante , Terapia Combinada , Supervivencia sin Enfermedad , Femenino , Humanos , Técnicas para Inmunoenzimas , Ligandos , Mastectomía Segmentaria , Persona de Mediana Edad , Estadificación de Neoplasias , Valor Predictivo de las Pruebas , Pronóstico , Radioterapia , Receptores de Progesterona/metabolismo
13.
Pharmacopsychiatry ; 35(1): 6-11, 2002 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-11819152

RESUMEN

It has been suggested that anticholinergic drugs impair immediate memory and working memory in patients with schizophrenia. Opinions remain divided as to the influence of anticholinergic drug withdrawal on the psychopathology and extrapyramidal side effects (EPS) in these patients. In our previous study, regional cerebral blood flow (rCBF) was reduced in all regions of patients taking anticholinergic drugs. Anticholinergic drugs were withdrawn in 21 schizophrenic inpatients. Immediate and verbal working memory, rCBF, psychopathology, and EPS were investigated before and after anticholinergic withdrawal. There was improvement in immediate memory, verbal working memory, and psychopathology, as well as an increase in rCBF after withdrawal from anticholinergic drugs. EPS showed no significant changes. Factors that may predict the improvement of immediate memory after withdrawal of anticholinergic drugs are more severe baseline psychopathology and use of a higher anticholinergic drug dose at baseline. Improvement of working memory may be predicted by a higher baseline rCBF in the left anterior cerebral artery region. Withdrawal from anticholinergics should be considered in schizophrenic patients, and it is important to taper these drugs over at least four weeks.


Asunto(s)
Enfermedades de los Ganglios Basales/inducido químicamente , Circulación Cerebrovascular/efectos de los fármacos , Antagonistas Colinérgicos/efectos adversos , Memoria/efectos de los fármacos , Esquizofrenia/tratamiento farmacológico , Adulto , Anciano , Antagonistas Colinérgicos/administración & dosificación , Femenino , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Esquizofrenia/fisiopatología , Síndrome de Abstinencia a Sustancias/fisiopatología , Aprendizaje Verbal/efectos de los fármacos
16.
Anticancer Res ; 21(4B): 2963-7, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11712794

RESUMEN

The purpose of this study was to compare the results of 133 cases (131 patients) of subcutaneous mastectomy with axillary dissection between 1983 and 1999 and 910 cases of radical mastectomy during the same period. The median follow-up period of the subcutaneous mastectomy group and the radical mastectomy group were 66 months and 81 months, respectively. The age at operation was significantly (p<0.01) younger in the subcutaneous mastectomy group than in the radical mastectomy group and the clinical stage was significantly (p<0.01) earlier. Lymph node metastasis was significantly (p<0.01) higher in the radical mastectomy than in the subcutaneous mastectomy group. There was no difference in ER status between the two groups. There was local recurrence in 5 (3.8%) members of the subcutaneous mastectomy group and in 12 (1.3%) members of the radical mastectomy group. There was no difference in disease-free survival and overall survival between the two groups. Divided into two subgroups by lymph node status, there was no difference in disease-free survival and overall survival between the two groups. Local recurrence occurred more frequently (p<0.05) in the subcutaneous mastectomy group, however, than in the radical mastectomy group when no lymph node metastasis was found. Multivariate analysis using the Cox hazard model showed that operation method and lymph node status were independent prognostic factors for local recurrence, whereas, lymph node status and ER status were independent prognostic factors of disease-free survival. In conclusion, subcutaneous mastectomy presents a risk factor for local recurrence, but the survival rate of the subcutaneous mastectomy group is as favourable as the radical mastectomy group.


Asunto(s)
Neoplasias de la Mama/cirugía , Mastectomía Radical , Mastectomía Subcutánea , Adulto , Factores de Edad , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Axila , Neoplasias de la Mama/química , Neoplasias de la Mama/tratamiento farmacológico , Neoplasias de la Mama/mortalidad , Neoplasias de la Mama/patología , Quimioterapia Adyuvante , Terapia Combinada , Ciclofosfamida/administración & dosificación , Supervivencia sin Enfermedad , Combinación de Medicamentos , Femenino , Fluorouracilo/administración & dosificación , Humanos , Japón/epidemiología , Tablas de Vida , Escisión del Ganglio Linfático , Metástasis Linfática , Persona de Mediana Edad , Mitomicina/administración & dosificación , Proteínas de Neoplasias/análisis , Recurrencia Local de Neoplasia , Prednisolona/administración & dosificación , Modelos de Riesgos Proporcionales , Receptores de Estrógenos/análisis , Estudios Retrospectivos , Factores de Riesgo , Análisis de Supervivencia , Tamoxifeno/administración & dosificación , Tegafur/administración & dosificación , Resultado del Tratamiento , Uracilo/administración & dosificación
17.
AJR Am J Roentgenol ; 177(6): 1429-35, 2001 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-11717101

RESUMEN

OBJECTIVE: The purpose of our study was to evaluate the quality of and motion artifacts on multidetector CT scans and to compare the results with those of and on electron beam CT scans for the assessment of coronary calcium scores. MATERIALS AND METHODS: First, 20 volunteers were scanned using multidetector CT. We compared the signal-to-noise ratio in the heart, motion artifacts at the heart border, and the highest CT values in the regions of the coronary arteries using single-sector and multisector reconstruction algorithms. Next, 60 patients with coronary calcified deposits underwent both multidetector CT and electron beam CT. We compared coronary calcium scores determined with multidetector CT using the two algorithms (thresholds of 90 and 130 H) with those determined using electron beam CT. RESULTS: The signal-to-noise ratio was higher and motion artifacts were reduced when we used the multisector algorithm. The highest CT value in the region of the coronary arteries exceeded 90 H in one of 55 arteries on the multisector algorithm images and 17 of 55 arteries on single-sector algorithm images (chi-square test, p < 0.01). In coronary calcium scoring, correlation coefficients ranged from 0.920 to 0.992 (Pearson's product moment) and from 0.932 to 0.969 (Spearman's rank correlation coefficient). CONCLUSION: Multidetector CT with a retrospective ECG-gating algorithm (multisector reconstruction) produced cardiac images with fewer motion artifacts and showed a high correlation with coronary calcium scores determined using electron beam CT. Therefore, multidetector CT is a potential tool for coronary calcium scoring.


Asunto(s)
Calcio/análisis , Vasos Coronarios/química , Tomografía Computarizada por Rayos X , Adulto , Algoritmos , Calcinosis/diagnóstico por imagen , Enfermedad Coronaria/diagnóstico por imagen , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
18.
J Steroid Biochem Mol Biol ; 78(1): 41-50, 2001 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-11530283

RESUMEN

The selective estrogen receptor modulator, 4-hydroxytamoxifen (4-OHT) is a full agonist at the transforming growth factor (TGF) alpha gene in ER negative breast cancer cells stably transfected with ER alpha cDNA (Levenson et al., Br. J. Cancer 77 (1998) 1812-1819). E(2) and 4-OHT increase TGF alpha mRNA and protein in a concentration dependent manner. The responses to E(2) and 4-OHT are blocked by the pure antiestrogen ICI 182,780, which does not induce TGF alpha. Transfected MDA-MB-231 cells contain functional ER alpha but no ER beta function was detected. Neo transfected cells that did not express ER alpha or cells stably transfected with the DNA binding domain mutant C202R/E203V which prevents gene activation did not induce TGF alpha mRNA after either E(2) or 4-OHT treatment. An examination of the time course for either 10 nM E(2) or 1 microM 4-OHT for MDA-MB-231 cells stably transfected with cDNA for ER alpha showed increases in TGF alpha mRNA within 2 or 3 h respectively. Cells pretreated with cycloheximide (1 microg/ml) showed induced TGF alpha mRNA in response to E(2) or 4-OHT but TGF alpha mRNA induction was blocked by actinomycin D (1 microg/ml). We conclude that both E(2) and 4-OHT induce TGF alpha by direct interaction of ER alpha with DNA and that ER beta is not involved in the estrogen-like response to 4-OHT in the MDA-MB-231 cells.


Asunto(s)
Estradiol/farmacología , Receptores de Estrógenos/metabolismo , Tamoxifeno/análogos & derivados , Tamoxifeno/farmacología , Factor de Crecimiento Transformador alfa/metabolismo , Northern Blotting , Western Blotting , Cicloheximida/farmacología , ADN Complementario/metabolismo , Dactinomicina/análogos & derivados , Dactinomicina/farmacología , Relación Dosis-Respuesta a Droga , Ensayo de Inmunoadsorción Enzimática , Antagonistas de Estrógenos , Receptor alfa de Estrógeno , Receptor beta de Estrógeno , Humanos , Luciferasas/metabolismo , Inhibidores de la Síntesis de la Proteína/farmacología , ARN Mensajero/metabolismo , Receptores de Estrógenos/biosíntesis , Transducción de Señal , Factores de Tiempo , Transcripción Genética , Transfección , Células Tumorales Cultivadas
20.
Surg Today ; 31(2): 149-51, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11291709

RESUMEN

We report herein the case of a 40-year-old man with grade II invasive ductal carcinoma of the breast (pT1, pN0, M0: stage I) in whom a recurrence developed shortly after completion of a 2-year course of tamoxifen and 5-fluorouracil therapy following a mastectomy. Although the metastatic tumor was estrogen receptor-positive, hormone therapy combined with chemotherapy had no significant effect on tumor growth, and the patient died from disseminated tumors 2 years 6 months after completion of the adjuvant therapy. It is noteworthy that the circulating estradiol level increased from 18.0 to 892.3 pg/ml during the period of tumor progression and dissemination. We interpret these findings as an indication of high aromatase activity in the metastatic tumors. We suggest that extending tamoxifen treatment to 5 years or longer be recommended for the standard adjuvant hormone therapy of male breast cancer to prevent the early recurrence of hormone-responsive disease.


Asunto(s)
Antineoplásicos Hormonales/farmacología , Neoplasias de la Mama Masculina/patología , Carcinoma Ductal de Mama/patología , Estradiol/sangre , Recurrencia Local de Neoplasia , Tamoxifeno/farmacología , Adulto , Antimetabolitos Antineoplásicos/uso terapéutico , Antineoplásicos Hormonales/uso terapéutico , Neoplasias de la Mama Masculina/tratamiento farmacológico , Neoplasias de la Mama Masculina/cirugía , Carcinoma Ductal de Mama/tratamiento farmacológico , Carcinoma Ductal de Mama/cirugía , Esquema de Medicación , Resistencia a Antineoplásicos , Quimioterapia Combinada , Resultado Fatal , Fluorouracilo/uso terapéutico , Humanos , Masculino , Tamoxifeno/uso terapéutico , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA